drugset / Trial / NCT06349759

Safety and Efficacy of 0.75% Phentolamine Ophthalmic Solution in Subjects With Post-refractive Surgery Visual Disturbances

NCT06349759

Phase 3 Completed 200 enrolled Ocuphire Pharma, Inc. Viatris Inc. · collab
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Safety and efficacy of 0.75% Phentolamine Ophthalmic Solution to improve mesopic low contrast visual acuity in subjects with post-refractive surgery visual disturbances.

Timeline

Start
2024-04-01
Primary completion
2025-04-17
Completion
2026-02-19

Drugs

EvaluationDrugModalityDoseRoute
Comparator Phentolamine Small molecule 0.75 % Other

Indications